Table 1.
Parameter | Fluconazole (F) study arm | Markers@ (M) study arm | Markers@ + Fluconazole (F + M) study arm | P value* (95% CI of difference) |
---|---|---|---|---|
CLcr measured | 145 ± 26 | 136 ± 21 | 138 ± 23 | 0.672† |
(ml min−1) | (103–178) | (101–163) | (98–174) | |
CLcr estimated | 142 ± 22 | 146 ± 32 | 144 ± 26 | 0.939† |
(ml min−1) | (115–180) | (104–216) | (116–186) | |
CLcrsecr | 17 ± 25 | 8 ± 33 | 0.473 | |
(ml min−1) | (−33–45) | (−40–50) | (−15,–33) | |
Sinistrin CL | 139 ± 44 | 143 ± 45 | 0.482 | |
(ml min−1) | (82–234) | (81–227) | (−16,–7) | |
Sinistrin Ae | 2286 ± 335 | 2447 ± 213 | 0.116 | |
(mg) | (1509–2645) | (2122–2760) | (−347,–24) | |
Sinistrin CLR | 119 ± 31 | 130 ± 40 | 0.317 | |
(ml min−1) | (80–187) | (76–207) | (−31,–9.6) | |
PAH CL | 697 ± 183 | 663 ± 166 | 0.398 | |
(ml min−1) | (449–1021) | (483–1061) | (−42,–111) | |
PAH Ae | 1379 ± 124 | 1459 ± 141 | 0.069 | |
(µmol) | (1210–1630) | (1190–1685) | (−158,−2) | |
PAH CLR | 469 ± 145 | 467 ± 146 | 0.945 | |
(ml min−1) | (284–713) | (337–855) | (−107,–111) | |
Net PAH CLsecr | 370 ± 130 | 359 ± 134 | 0.631 | |
(ml min−1) | (187–583) | (252–729) | (−41,–63) |
Paired t-test: Markers (M) vs Markers + Fluconazole (F + M) a. 95% confidence interval of differences.
anova: Fluconazole (F) vs Markers (M) vs Markers + Fluconazole (F + M) @Markers were sinistrin, PAH and pindolol.